SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013396
Filing Date
2022-05-16
Accepted
2022-05-13 17:35:59
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 755811
2 ex31-1.htm EX-31.1 11824
3 ex31-2.htm EX-31.2 12044
4 ex32-1.htm EX-32.1 5590
  Complete submission text file 0001493152-22-013396.txt   4480935

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20220331.xsd EX-101.SCH 32997
6 XBRL CALCULATION FILE brtx-20220331_cal.xml EX-101.CAL 44619
7 XBRL DEFINITION FILE brtx-20220331_def.xml EX-101.DEF 156840
8 XBRL LABEL FILE brtx-20220331_lab.xml EX-101.LAB 317648
9 XBRL PRESENTATION FILE brtx-20220331_pre.xml EX-101.PRE 251950
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 711635
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 22924242
SIC: 8090 Services-Misc Health & Allied Services, NEC